WebJun 28, 2024 · GARDEN CITY, N.Y., June 28, 2024 — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond … WebJan 4, 2024 · Potential Beyond Air, Inc. ( NASDAQ:XAIR) shareholders may wish to note that the CEO & Chairman of the Board, Steven Lisi, recently bought US$203k worth of stock, …
Beyond Air® Announces Participation at Two Upcoming Investor ...
WebFeb 22, 2024 · Beyond Air is a medical device and biopharmaceutical company dedicated to harnessing the power of nitric oxide through its revolutionary NO Generator and Delivery System, LungFit, that uses NO... WebFeb 22, 2024 · Beyond Air is a medical device and biopharmaceutical company dedicated to harnessing the power of nitric oxide through its revolutionary NO Generator and Delivery System, LungFit, that uses NO... doh ri license lookup
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q1 2024 Results - SeekingAlpha
WebNov 4, 2024 · Steve Lisi, Chairman of the Board, and CEO and Chairman of the Board of Beyond Air Selena Chaisson, M.D., Director, and CEO of Beyond Cancer Amir Avniel, Executive Director, and... WebNov 12, 2024 · Beyond Air, Inc. ( NASDAQ: XAIR) Q2 2024 Earnings Conference Call November 11, 2024 4:30 PM ET Company Participants Maria Yonkoski - Head of Investor … WebApr 10, 2024 · Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. Beyond Air, Inc. Fundamentals … dohrana bebe od 6 mjeseci tablica